trial
as of 2026-07-01Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
NCTId NCT01714011
at a glance
Phase 4 · Completed
Enrollment 175 (actual)
Sponsored by University of Malaya
Primary completion 2011-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
175 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2009-05
Primary completion
2011-09
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of MalayaLead Sponsor
Investigators
2
Mas Ayu Said, MBBS,MPHStudy Director
Ahmad Hatim Sulaiman, MBBS,MPMPrincipal Investigator
Sites
1 total
Kuala Lumpur, Malaysia
Facts & assertions
4 sourced
Enrollment
175
Phase
PHASE4
Primary Completion Date
2011-09
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
company
indication
investigator